Compare OBK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | PLSE |
|---|---|---|
| Founded | 1912 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 3.6B |
| IPO Year | 2018 | 2015 |
| Metric | OBK | PLSE |
|---|---|---|
| Price | $53.22 | $51.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $46.67 | $22.00 |
| AVG Volume (30 Days) | 133.6K | ★ 578.9K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.43 | $840.00 |
| Revenue Next Year | $5.79 | $287.54 |
| P/E Ratio | $27.26 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.13 | $12.56 |
| 52 Week High | $55.57 | $58.90 |
| Indicator | OBK | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 57.51 |
| Support Level | $52.46 | $15.64 |
| Resistance Level | $55.17 | $58.90 |
| Average True Range (ATR) | 0.95 | 4.47 |
| MACD | -0.07 | -0.70 |
| Stochastic Oscillator | 32.54 | 42.37 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.